{"id":"W3029703953","doi":"10.1200/jco.2020.38.15_suppl.tps11569","title":"SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Fludarabine; Context (archaeology); Internal medicine; Synovial sarcoma; Myxoid liposarcoma; Phases of clinical research; Sarcoma; Oncology; Clinical trial; Liposarcoma; Surgery; Cyclophosphamide; Chemotherapy; Pathology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001459397,0.001769575,0.001301038,0.0004848923,0.0004365697,0.000999058,0.001112934,0.001718523,0.008290582],"category_scores_gemma":[0.0006768233,0.0005519097,0.001168077,0.0003942401,0.0009143178,0.001039273,0.000458276,0.003996475,0.001400704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009202361,"about_ca_system_score_gemma":0.001332377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008009284,"about_ca_topic_score_gemma":0.002594394,"domain_scores_codex":[0.9995992,0.000178194,0.00001823703,0.00006378833,0.00004636922,0.00009432646],"domain_scores_gemma":[0.9995166,0.00008633256,0.00009496193,0.00002843085,0.0000211716,0.0002524626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6582374,0.0679272,0.005508912,0.001813396,0.001342664,0.0009035398,0.0006500715,0.004682758,0.07059181,0.001491753,0.02005503,0.1667955],"study_design_scores_gemma":[0.5260206,0.4578826,0.004743036,0.00005638169,0.0002589067,0.0005502012,0.00006936774,0.001353099,0.003877257,0.0003722825,0.004779265,0.00003695934],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834825,0.003471061,0.0008369044,0.001117674,0.0002352188,0.003604426,0.001892174,0.0002477837,0.005112209],"genre_scores_gemma":[0.9777547,0.002500209,0.002173773,0.001838855,0.0003205701,0.003707287,0.00423221,0.00004795603,0.00742448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008290582,"threshold_uncertainty_score":0.02773476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1272023625399576,"score_gpt":0.4742158092952539,"score_spread":0.3470134467552962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}